| Keyword search (4,163 papers available) | ![]() |
"Immunotherapy" Keyword-tagged Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Thermal sonogenetics for adoptive cell transfer therapy | Baez A; Hazel K; Guertin Z; Fong E; Manus MM; Kaloyannis A; Helfield B; | 41748028 BIOLOGY |
| 2 | Shear Stress and Microbubble-Mediated Modulation of Endothelial Cell Immunobiology | Memari E; Singh D; Alkins R; Helfield B; | 40657183 PHYSICS |
| 3 | Immunomodulation of human T cells by microbubble-mediated focused ultrasound | Baez A; Singh D; He S; Hajiaghayi M; Gholizadeh F; Darlington PJ; Helfield B; | 39502696 BIOLOGY |
| 4 | Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer | Memari E; Khan D; Alkins R; Helfield B; | 38266715 BIOLOGY |
| 5 | Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies | Lu H; Hong T; Jiang Y; Whiteway M; Zhang S; | 37307922 BIOLOGY |
| Title: | Candidiasis: from cutaneous to systemic, new perspectives of potential targets and therapeutic strategies | ||||
| Authors: | Lu H, Hong T, Jiang Y, Whiteway M, Zhang S | ||||
| Link: | https://pubmed.ncbi.nlm.nih.gov/37307922/ | ||||
| DOI: | 10.1016/j.addr.2023.114960 | ||||
| Publication: | Advanced drug delivery reviews | ||||
| Keywords: | Antifungal drugs; Antifungal immunotherapy; Antifungal targets; Candidiasis; Cutaneous infection; Systemic infection; | ||||
| PMID: | 37307922 | Category: | Date Added: | 2023-06-13 | |
| Dept Affiliation: | BIOLOGY | ||||
Description: |
Candidiasis is an infection caused by fungi from a Candida species, most commonly Candida albicans. C. albicans is an opportunistic fungal pathogen typically residing on human skin and mucous membranes of the mouth, intestines or vagina. It can cause a wide variety of mucocutaneous barrier and systemic infections; and becomes a severe health problem in HIV/AIDS patients and in individuals who are immunocompromised following chemotherapy, treatment with immunosuppressive agents or after antibiotic-induced dysbiosis. However, the immune mechanism of host resistance to C. albicans infection is not fully understood, there are a limited number of therapeutic antifungal drugs for candidiasis, and these have disadvantages that limit their clinical application. Therefore, it is urgent to uncover the immune mechanisms of the host protecting against candidiasis and to develop new antifungal strategies. This review synthesizes current knowledge of host immune defense mechanisms from cutaneous candidiasis to invasive C. albicans infection and documents promising insights for treating candidiasis through inhibitors of potential antifungal target proteins. |



